Anti-Embolism Stockings Market Trends Indicate US$ 1.11 Billion Revenue by 2032 - Persistence Market Research

✅ Anti-Embolism Stockings Market Overview

The global anti-embolism stockings market stood at US$ 783.6 million in 2025 and is projected to grow at a steady CAGR of 5.2%, reaching US$ 1,117.4 million by 2032. Anti-embolism stockings are an essential component of compression therapy, designed to reduce the risk of venous thromboembolism (VTE) in bedridden and post-operative patients. Their ability to promote healthy blood flow, decrease venous wall dilation, and support valvular function makes them indispensable in modern medical settings.

A major growth driver for the market is the rising global elderly population, which is more susceptible to blood clots and chronic vascular conditions. Additionally, the increasing incidence of obesity, sedentary lifestyles, and chronic illnesses like cancer and cardiovascular diseases have escalated the demand for preventive solutions such as anti-embolism stockings. Technological advancements and improved access to healthcare services have also significantly contributed to the market's expansion.

Among the various segments, calf-length anti-embolism stockings dominate the product category, accounting for 64.3% of the total market share in 2024, owing to their comfort and efficacy. Regionally, North America leads the market, largely due to the high prevalence of VTE and greater awareness among healthcare professionals and patients. The United States alone contributed 87.8% of North America's market share in 2024, driven by a well-developed healthcare system, increasing online sales, and robust public health campaigns focused on DVT prevention.

✅Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/33355

✅ Key Highlights from the Report

➤ The global anti-embolism stockings market is projected to reach US$ 1,117.4 million by 2032.
➤ Calf-length stockings held a dominant 64.3% market share in 2024.
➤ The market grew at a CAGR of 4.0% between 2019 and 2024, driven by aging demographics.
➤ The male demographic leads with 63.1% of the market due to higher obesity rates.
➤ The U.S. accounted for 87.8% of the North American market in 2024.
➤ Online retail sales of anti-embolism stockings are growing rapidly in developed economies.

✅ Market Segmentation

The anti-embolism stockings market can be segmented based on product type, demographic focus, and end-user.

By product type, the market is bifurcated into calf-length and thigh-length stockings. Calf-length stockings dominate the market due to their superior patient compliance, ease of use, and affordability. These are particularly suitable for post-operative and bedridden patients, making them the preferred choice in hospitals and care homes. Thigh-length stockings, though effective, are less popular due to the discomfort and difficulty associated with putting them on, especially among elderly or physically challenged patients.

From a demographic perspective, men account for 63.1% of the market share and are expected to maintain dominance with a CAGR of 5.4% through 2032. This is attributed to the higher prevalence of obesity among men, a major risk factor for deep vein thrombosis (DVT). On the end-user front, post-operative patients form the largest consumer group, given that surgery significantly increases the risk of thromboembolism. Ambulatory patients and pregnant women also represent notable segments, as these groups often require temporary support to prevent venous complications.

✅ Regional Insights

North America & Europe

North America leads the anti-embolism stockings market, with the United States accounting for the lion's share (87.8%). The region benefits from a highly developed healthcare infrastructure, increasing awareness about DVT prevention, and a surge in online retail for medical products. The U.S. alone sees nearly 900,000 DVT cases annually, making anti-embolism stockings a necessity in many healthcare facilities.

In Europe, the United Kingdom is a standout market, capturing 22% of the regional share in 2024. Driven by strong public health initiatives, increased consumer awareness, and the growing prevalence of lifestyle-related health issues, the UK market is projected to grow at a CAGR of 4.9% through 2032. Adoption is further accelerated by technological innovations in compression therapy and orthopedic support.

Asia-Pacific

In South Asia, India is emerging as a promising market with 33.2% of the regional share in 2024. The country is witnessing rising cases of DVT, largely due to prolonged immobility, obesity, and increasing surgical interventions. Growing healthcare infrastructure and awareness are set to boost demand. With a CAGR of 4.3% expected through 2032, India is a strategic region for manufacturers seeking long-term growth. Meanwhile, East Asia, led by China and Japan, is also showing significant promise due to demographic aging and urban lifestyle changes.

✅ Market Drivers

One of the primary drivers of the anti-embolism stockings market is the increasing global geriatric population, which is more prone to venous disorders and limited mobility. According to the WHO, the number of people aged 60 and above is projected to double by 2050. This demographic shift directly correlates with a higher risk of DVT, thus propelling demand for compression-based preventive products.

Another major driver is the rising incidence of chronic diseases such as cancer, diabetes, and heart conditions, all of which can impair blood circulation and increase clotting risk. Technological advancements in fabric materials, integration of smart sensors, and improved stocking designs are also helping enhance the usability and effectiveness of anti-embolism stockings, driving broader adoption among both patients and clinicians.

✅ Market Restraints

Despite strong growth prospects, the anti-embolism stockings market faces several critical restraints. Improper usage of the product can lead to adverse skin conditions, especially in elderly or malnourished patients. This can discourage use and negatively impact the product's reputation. Moreover, challenges like inconsistent compression application due to sizing issues or material degradation can result in suboptimal therapeutic outcomes.

Additionally, the lack of standardized manufacturing guidelines and limited awareness in emerging economies hinder market expansion. Regulatory hurdles, particularly concerning product efficacy and safety, add another layer of complexity for manufacturers. These combined factors can slow down the market's penetration in underdeveloped healthcare systems and impact user confidence.

✅Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/33355

✅ Market Opportunities

The market presents significant opportunities for innovation and growth. One emerging trend is the integration of wearable technologies, such as sensors that monitor blood flow and pressure, to provide real-time data and improve patient outcomes. These smart stockings can significantly enhance the precision and efficacy of DVT prevention.

Furthermore, there's growing potential in underserved and emerging markets, especially in regions like Africa, Southeast Asia, and parts of Latin America, where the aging population is increasing and access to healthcare is improving. Manufacturers who focus on cost-effective, easy-to-use designs for these markets stand to gain a competitive advantage. The treatment of cancer-related venous disorders using compression therapy is another underexplored but promising area for future expansion.

✅ Frequently Asked Questions

➤ How Big is the Anti-Embolism Stockings Market in 2025?
➤ What is the Projected Growth Rate of the Anti-Embolism Stockings Market?
➤ Who are the Key Players in the Global Market for Anti-Embolism Stockings?
➤ What is the Market Forecast for Anti-Embolism Stockings through 2032?
➤ Which Region is estimated to dominate the Industry through the Forecast Period?

✅ Company Insights

✦ Medtronic (Covidien)
✦ Sigvaris
✦ Medi
✦ BSN Medical
✦ Juzo
✦ 3M
✦ Bauerfeind AG
✦ Thuasne Corporate
✦ Pretty Legs Hosiery
✦ Salzmann-Group
✦ Paul Hartmann
✦ Cizeta Medicali
✦ Belsana Medical
✦ Gloria Med
✦ Zhende Medical Group

✅ Recent Market Developments

■ In May 2019, 3M Company acquired Acelity Inc. and KCI subsidiaries to broaden its compression therapy portfolio.
■ In January 2021, Thuasne SAS acquired Knit-Rite Inc. and Therafirm, strengthening its position in the U.S. compression market.

✅ Reasons to Buy the Report

Gain a comprehensive understanding of current market dynamics and trends.

Identify key growth opportunities across regions and product types.

Evaluate the competitive landscape and recent strategic developments.

Analyze the impact of technological advancements on market expansion.

Plan market entry or expansion strategies with reliable, data-driven insights.

The global anti-embolism stockings market is on a clear upward trajectory, fueled by demographic shifts, chronic illness prevalence, and continuous innovation. For healthcare providers, investors, and manufacturers, this sector represents both a vital medical necessity and a lucrative business opportunity-especially for those who act now to address gaps in usage education, affordability, and smart technology integration.

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.